SCHEMBL131764

SCHEMBL131764

C#CCCCCCN

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL132572 1.00 DNM1 (0.50)
SCHEMBL136300 1.00 DNM1 (0.50)
SCHEMBL128767 1.00 DNM1 (0.50)
SCHEMBL130312 1.00 DNM1 (0.50)
SCHEMBL130351 1.00
SCHEMBL132720 1.00 DNM1 (0.50)
SCHEMBL3626055 1.00 DNM1 (0.50)
SCHEMBL30836945 1.00 DNM1 (0.50)
SCHEMBL133387 1.00 DNM1 (0.50)
SCHEMBL129519 1.00 DNM1 (0.50)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5241018-A Shaped articles for air- and spacecraft UBE INDUSTRIES, LTD. (JP) 1993-08-31 US claimed
US-5081196-A Containing an acetylenically unsaturated monoamine compound UBE INDUSTRIES, LTD. (JP) 1992-01-14 US claimed
EP-0357367-A2 Terminal-modified aromatic imide oligomer composition UBE INDUSTRIES, LTD. (JP) 1990-03-07 EP claimed
US-12624044-B2 SMARCA degraders and uses thereof KYMERA THERAPEUTICS, INC. (US) 2026-05-12 US disclosed
CN-119504834-A PD-L1 protein degradation agent with silicon-containing group as hydrophobic label, preparation method, pharmaceutical composition and application thereof 南开大学 2025-02-25 CN disclosed
WO-2024150578-A1 HEAT-CURABLE RESIN COMPOSITION, CURED PRODUCT, AND ELECTRONIC COMPONENT JNC株式会社 2024-07-18 WO disclosed
CN-118146225-A Pyrazolotriazine compound, preparation method thereof, pharmaceutical composition and application 中国科学院上海药物研究所 2024-06-07 CN disclosed
CN-115260161-B Self-assembled protein degradation agent with tumor cell specificity and preparation method and application thereof 西安交通大学 2024-02-09 CN disclosed
CN-117186076-A Protein degradation agent with adamantane as hydrophobic group, preparation method, pharmaceutical composition and application thereof 南开大学 2023-12-08 CN disclosed
US-11833208-B2 PLK1 selective degradation inducing compound UPPTHERA, INC. (KR) 2023-12-05 US disclosed
US-11833208-B2 PLK1 selective degradation inducing compound UPPTHERA, INC. (KR) 2023-12-05 US disclosed
US-5081196-A Containing an acetylenically unsaturated monoamine compound UBE INDUSTRIES, LTD. (JP) 1992-01-14 US disclosed
EP-0420593-A2 Terminal-modified imide oligomer composition UBE INDUSTRIES, LTD. (JP) 1991-04-03 EP disclosed
EP-0395020-A2 Terminal-modified imide oligomer composition UBE INDUSTRIES, LTD. (JP) 1990-10-31 EP disclosed
EP-0393638-A2 Thermosetting resin compostion and thermosetting dry film UBE INDUSTRIES, LTD. (JP) 1990-10-24 EP disclosed
US-4963645-A UNSATURATED END GROUPS UBE INDUSTRIES, LTD. (JP) 1990-10-16 US disclosed
EP-0371154-A1 Prepreg of reinforced imide oligomer UBE INDUSTRIES, LTD. (JP) 1990-06-06 EP disclosed
US-4921745-A Honeycomb structure of aromatic polyimide UBE INDUSTRIES, LTD. (JP) 1990-05-01 US disclosed
EP-0357367-A2 Terminal-modified aromatic imide oligomer composition UBE INDUSTRIES, LTD. (JP) 1990-03-07 EP disclosed
EP-0304913-A2 Terminal-modified imide oligomer and solution composition of the same UBE INDUSTRIES, LTD. (JP) 1989-03-01 EP disclosed